UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Affibody Molecules as Targeting Vectors for PET Imaging

Cancers, 2020-03, Vol.12 (3), p.651

2020

Volltextzugriff (PDF)

66Ga-PET-imaging of GRPR-expression in prostate cancer: production and characterization of [66Ga]Ga-NOTA-PEG2-RM26

Scientific reports, 2021-02, Vol.11 (1), p.1-12, Article 3631

2021

Volltextzugriff (PDF)

PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology

International journal of molecular sciences, 2021-04, Vol.22 (7), p.3663

2021

Volltextzugriff (PDF)

Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond

EJNMMI radiopharmacy and chemistry, 2020-06, Vol.5 (1), p.16-26, Article 16

2020

Volltextzugriff (PDF)

Radionuclides in Diagnostics and Therapy of Malignant Tumors: New Development

Cancers, 2022-01, Vol.14 (2), p.297

2022

Volltextzugriff (PDF)

Radiolabeled GRPR Antagonists for Imaging of Disseminated Prostate Cancer - Influence of Labeling Chemistry on Targeting Properties

Current medicinal chemistry, 2020-01, Vol.27 (41), p.7090-7111

2020

Volltextzugriff (PDF)

Targeted nuclear medicine. Seek and destroy

Russian chemical reviews, 2022-04, Vol.91 (3), p.RCR5034

2022

Volltextzugriff (PDF)

Engineering of affibody molecules for therapy and diagnostics

Methods in molecular biology (Clifton, N.J.), 2012, Vol.899, p.103

2012

Volltextzugriff (PDF)

Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [68Ga]ABY-025 Affibody PET/CT

Theranostics, 2016, Vol.6 (2), p.262-271

2016

Volltextzugriff (PDF)

Evaluation of an antibody-PNA conjugate as a clearing agent for antibody-based PNA-mediated radionuclide pretargeting

Scientific reports, 2020-11, Vol.10 (1), p.20777, Article 20777

2020

Volltextzugriff (PDF)

Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m

International journal of molecular sciences, 2024-04, Vol.25 (7), p.3615

2024

Volltextzugriff (PDF)

VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread

Nature communications, 2016-03, Vol.7 (1), p.11017-11017, Article 11017

2016

Volltextzugriff (PDF)

Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain

The Journal of biological chemistry, 2011-02, Vol.286 (7), p.5234-5241

2011

Volltextzugriff (PDF)

Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfalls

The lancet oncology, 2010-10, Vol.11 (10), p.992-1000

2010

Volltextzugriff (PDF)

Study of the optical properties of silver nanoparticle layers and Si‐based nanostructure layers

physica status solidi (b), 2017-06, Vol.254 (6), p.n/a

2017

Volltextzugriff (PDF)

Preclinical Evaluation of a Novel High-Affinity Radioligand [ 99m Tc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA)

International journal of molecular sciences, 2023-12, Vol.24 (24), p.17391

2023

Volltextzugriff (PDF)

Evaluation of Approaches for the Assessment of HER2 Expression in Breast Cancer by Radionuclide Imaging Using the Scaffold Protein [ 99m Tc]Tc-ADAPT6

Pharmaceutics, 2024-03, Vol.16 (4), p.445

2024

Volltextzugriff (PDF)

Radionuclide molecular imaging using Affibody molecules

Current pharmaceutical biotechnology, 2010-09, Vol.11 (6), p.581-589

2010

Volltextzugriff (PDF)

Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion

International journal of molecular sciences, 2024-04, Vol.25 (8), p.4246

2024

Volltextzugriff (PDF)

Increase in negative charge of 68Ga/chelator complex reduces unspecific hepatic uptake but does not improve imaging properties of HER3-targeting affibody molecules

Scientific reports, 2019-11, Vol.9 (1), Article 17710

2019

Volltextzugriff (PDF)

Tumor imaging using a picomolar affinity HER2 binding affibody molecule

Cancer research (Chicago, Ill.), 2006-04, Vol.66 (8), p.4339-4348

2006

Volltextzugriff (PDF)

Optimization of HER3 expression imaging using affibody molecules: Influence of chelator for labeling with indium-111

Scientific reports, 2019-01, Vol.9 (1), p.655, Article 655

2019

Volltextzugriff (PDF)

Direct Intra-Patient Comparison of Scaffold Protein-Based Tracers, [ 99m Tc]Tc-ADAPT6 and [ 99m Tc]Tc-(HE) 3 -G3, for Imaging of HER2-Positive Breast Cancer

Cancers, 2023-06, Vol.15 (12), p.3149

2023

Volltextzugriff (PDF)

Indirect Radioiodination of DARPin G3 Using N-succinimidyl- Para -Iodobenzoate Improves the Contrast of HER2 Molecular Imaging

International journal of molecular sciences, 2019-06, Vol.20 (12), p.3047

2019

Volltextzugriff (PDF)

Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26

Scientific reports, 2019-11, Vol.9 (1), p.17086, Article 17086

2019

Volltextzugriff (PDF)

1 – 25 von 813

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(734)
Mit Volltextzugriff
(744)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Affibody Molecules as Targeting Vectors for PET Imaging

66Ga-PET-imaging of GRPR-expression in prostate cancer: production and characterization of [66Ga]Ga-NOTA-PEG2-RM26

PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology

Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond

Radionuclides in Diagnostics and Therapy of Malignant Tumors: New Development

Radiolabeled GRPR Antagonists for Imaging of Disseminated Prostate Cancer - Influence of Labeling Chemistry on Targeting Properties

Targeted nuclear medicine. Seek and destroy

Engineering of affibody molecules for therapy and diagnostics

Measuring HER2-Receptor Expression In Metastatic Breast Cancer Using [68Ga]ABY-025 Affibody PET/CT

Evaluation of an antibody-PNA conjugate as a clearing agent for antibody-based PNA-mediated radionuclide pretargeting

Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m

VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread

Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain

Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfalls

Study of the optical properties of silver nanoparticle layers and Si‐based nanostructure layers

Preclinical Evaluation of a Novel High-Affinity Radioligand [ 99m Tc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA)

Evaluation of Approaches for the Assessment of HER2 Expression in Breast Cancer by Radionuclide Imaging Using the Scaffold Protein [ 99m Tc]Tc-ADAPT6

Radionuclide molecular imaging using Affibody molecules

Preclinical Evaluation of HER2-Targeting DARPin G3: Impact of Albumin-Binding Domain (ABD) Fusion

Increase in negative charge of 68Ga/chelator complex reduces unspecific hepatic uptake but does not improve imaging properties of HER3-targeting affibody molecules

Tumor imaging using a picomolar affinity HER2 binding affibody molecule

Optimization of HER3 expression imaging using affibody molecules: Influence of chelator for labeling with indium-111

Direct Intra-Patient Comparison of Scaffold Protein-Based Tracers, [ 99m Tc]Tc-ADAPT6 and [ 99m Tc]Tc-(HE) 3 -G3, for Imaging of HER2-Positive Breast Cancer

Indirect Radioiodination of DARPin G3 Using N-succinimidyl- Para -Iodobenzoate Improves the Contrast of HER2 Molecular Imaging

Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26

Suchergebnisse filtern